1. Ultrasound Cyclo-Plasty in Patients with Glaucoma: 1-Year Results from a Multicentre Prospective Study
- Author
-
Fulvio Bergamini, Carlo Enrico Traverso, Stefano Sebastiani, Aldo Vagge, Paolo Corazza, Luciana Carmassi, Marco Pellegrini, Lara Enrica Urbini, Giuseppe Giannaccare, Emilio C. Campos, and Giannaccare G, Vagge A, Sebastiani S, Urbini LE, Corazza P, Pellegrini M, Carmassi L, Bergamini F, Traverso CE, Campos EC.
- Subjects
Adult ,Male ,Intraocular pressure ,medicine.medical_specialty ,Visual acuity ,genetic structures ,Ultrasound cyclo-plasty ,medicine.medical_treatment ,Visual Acuity ,Glaucoma ,Ciliary body ,NO ,Tonometry ,Tonometry, Ocular ,Cellular and Molecular Neuroscience ,Glaucoma, Ultrasound cyclo-plasty, High-intensity focused ultrasound, Intraocular pressure, Ciliary body ,Ophthalmology ,Ocular ,medicine ,80 and over ,Humans ,In patient ,Prospective Studies ,Prospective cohort study ,Aged ,Aged, 80 and over ,High-intensity focused ultrasound ,Ciliary Body ,Female ,Follow-Up Studies ,High-Intensity Focused Ultrasound Ablation ,Intraocular Pressure ,Middle Aged ,Visual Fields ,Treatment Outcome ,Sensory Systems ,business.industry ,Ultrasound ,General Medicine ,medicine.disease ,First generation ,eye diseases ,sense organs ,medicine.symptom ,business ,Sensory System - Abstract
Purpose: The aim of this study was to evaluate the safety and efficacy of ultrasound cyclo-plasty (UCP) for reducing intraocular pressure (IOP) in patients with glaucoma. Methods: This is a multicentre prospective study conducted in 3 Italian glaucoma centres. UCP was performed by EyeOP1, which delivers ultrasound beams using 6 piezoelectric transducers activated for 4/6 s (first generation) or 8 s (second generation). Primary outcomes were the mean IOP reduction and the rates of success after 1 year. Secondary outcomes were the mean IOP reduction at each follow-up, and the reduction of the number of hypotensive medications. Results: In total, 49 eyes from 47 patients were treated. One year postoperatively, the mean IOP had decreased from 27.7 ± 9.2 to 19.8 ± 6.9 mm Hg (p < 0.001), and the mean number of hypotensive drops and tablets had decreased from 3.2 and 0.5 to 2.3 and 0.2, respectively (p < 0.05). Postoperative IOP reduction was significantly related to preoperative IOP (r2 = 0.5034; p < 0.0001). Second-generation probes determined a significantly higher IOP reduction (p < 0.05). Qualified success was achieved in 25 eyes (51.1%) and complete success in 21 (42.9%), while failure was recorded in 12 (24.5%). Conclusions: UCP is safe and effective for reducing IOP. The procedure determines a greater IOP reduction in patients with higher preoperative IOP. Second-generation probes improve outcomes without detrimental effects on safety.
- Published
- 2019